Quantcast
Last updated on April 20, 2014 at 21:20 EDT

Health News Archive - February 16, 2010

SOUTH SAN FRANCISCO, Calif., Feb. 16 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) announced that its senior management team will host a conference call, and simultaneous audio webcast, today at 8:30 a.m. EST (5:30 a.m.

LACHEN, Switzerland, February 16 /PRNewswire/ -- - Octapharma to Set New Standards in IVIG Development, Focused on Improving Outcomes For Patients and Physicians Octapharma AG today announced the start of the first of a series of Phase III studies for its new 10% high purity intravenous immunoglobulin (IVIG). The study will investigate the efficacy and safety of this novel immunoglobulin in the treatment of primary immune deficiency and, together with results from additional upcoming studies, will support its regulatory filing in Europe and the US. Commenting on the start of the study, Kim Björnstrup, Deputy Chairman of Octapharma Group said, "The development of our novel 10% IVIG is part of our ongoing commitment to invest in the development of protein based immunotherapies and in particular in IgG preparations.

MIAMI, Feb. 16 /PRNewswire/ -- Pharmaceutical manufacturers around the world now have access to high-level, FDA support services at the touch of a button. VPCI (Vectech Pharmaceutical Consultants International) has pioneered a "Virtual GMP Consulting" service.

NEW YORK, Feb. 16 /PRNewswire/ -- Paco Sosa, a dachshund who turned 20 last September, and whose strong spirit had cheated death several times in recent years, passed away on February 12.

LONDON, Feb. 16 /PRNewswire/ -- Europe's patient population is moving towards long-term care and homecare from hospitals and other clinical settings. Consequently, the significance of nursing and residential care services is on the rise.

KINGWOOD, Texas, Feb. 16 /PRNewswire-FirstCall/ -- International Merchant Advisors, Inc. (Pink Sheets: IMAI.PK) www.imaiinc.com announced today that the company has signed a letter of intent to purchase a minority interest in Assured Pharmacy, Inc.

REDWOOD CITY, Calif., Feb. 16 /PRNewswire/ -- Ingenuity® Systems, the leading provider of information solutions for life science researchers, today announced the addition of dynamic reports, new weekly content updates, and metabolomics workflow support in the latest release of IPA® software.

NEW YORK, Feb. 16 /PRNewswire-FirstCall/ -- Delcath Systems, Inc. (Nasdaq: DCTH), which is testing its proprietary treatment system for metastatic cancers to the liver, announced today that the U.S.